New issues for copper-64: from precursor to innovative PET tracers in clinical oncology.

Current radiopharmaceuticals

Volumn 6, Issue 3, 2013, Pages 117-123

  Evangelista, Laura ^a   Luigi, Mansi ^b   Cascini, Giuseppe Lucio ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; COPPER; PACLITAXEL; RADIOPHARMACEUTICAL AGENT;

BREAST TUMOR; CHEMISTRY; DEGENERATIVE DISEASE; DRUG RESISTANCE; FEMALE; HOMEOSTASIS; HUMAN; MALE; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; PROSTATE TUMOR; REVIEW; SCINTISCANNING; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CISPLATIN; COPPER RADIOISOTOPES; DRUG RESISTANCE, NEOPLASM; FEMALE; HOMEOSTASIS; HUMANS; MALE; NEURODEGENERATIVE DISEASES; PACLITAXEL; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS;

MLCS; MLOWN;

EID: 84901564184     PISSN: None     EISSN: 18744729     Source Type: Journal    
DOI: 10.2174/18744710113069990020     Document Type: Review

References (0)